Cerebral tissue repair and atrophy after embolic stroke in rat: A magnetic resonance imaging study of erythropoietin therapy

Journal of Neuroscience Research

Volumn 88, Issue 14, 2010, Pages 3206-3214

  Ding, Guangliang ^a   Jiang, Quan ^a   Li, Lian ^a   Zhang, Li ^a   Wang, Ying ^a   Zhang, Zheng Gang ^a   Lu, Mei ^a   Panda, Swayamprava ^a   Li, Qingjiang ^a   Ewing, James R ^a   Chopp, Michael ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Brain atrophy; Cerebral tissue repair; Embolic stroke; Erythropoietin; Magnetic resonance imaging

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN ISCHEMIA; BRAIN TISSUE; BRAIN VENTRICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; EMBOLIC STROKE; EMBOLISM; HEMISPHERE; HISTOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TISSUE REPAIR; TREATMENT OUTCOME; WHITE MATTER;

ANIMALS; ATROPHY; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; INTRACRANIAL EMBOLISM; MAGNETIC RESONANCE IMAGING; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; STROKE;

EID: 78149306110     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22470     Document Type: Article

References (51)

1. Adams HP, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ. 2003. Guidelines for the early management of patients with ischemic stroke. Stroke 34: 1056-1083.
2. Adams HP, Adams RJ, del Zoppo GJ, Goldstein LB. 2005. Guidelines for the early management of patients with ischemic stroke. Stroke 36: 916-921.
3. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. 2002. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8: 963-970.
4. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. 2000. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97: 10526-10531.
5. Cramer SC, Chopp M. 2000. Recovery recapitulates ontogeny. Trends Neurosci 23: 265-271.
6. Dereski MO, Chopp M, Knight RA, Rodolosi LC, Garcia JH. 1993. The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat. Acta Neuropathol 85: 327-333.
7. Ding G, Jiang Q, Zhang L, Zhang ZG, Knight R, Soltanian-Zadeh H, Lu M, Ewing J, Li Q, Whitton PA, Chopp M. 2004. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat. JNeurol Sci 223: 135-143.
8. Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Ledbetter KA, Gollapalli L, Panda S, Li Q, Ewing JR, Chopp M. 2008a. Angiogenesis detected after embolic stroke in rat brain using magnetic resonance T2*WI. Stroke 39: 1563-1568.
9. Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Ledbetter KA, Panda S, Davarani SPN, Athiraman H, Li Q, Ewing JR, Chopp M. 2008b. Magnetic resonance imaging investigation of axonal remodeling and angiogenesis after embolic stroke in sildenafil-treated rats. J Cereb Blood Flow & Metab 28: 1440-1448.
10. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jaehnig P, Herrmann M, Knauth M, Baehr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C. 2009. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40: e647-e656.
11. Ghezzi P, Brines M. 2004. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 11: S37-S44.
12. Grotta JC, Burgin WS, El-Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexanderov AV. 2001. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 58: 2009-2013.
13. Haacke ME, Xu Y, Cheng YC, Reichenbach JR. 2004. Susceptibility weighted imaging (SWI). Magn Reson Med 52: 612-618.
14. Hoehn-Berlage M, Eis M, Back T, Kohno K, Yamashita K. 1995. Changes of relaxation times (T1, T2) and apparent diffusion coefficient after permanent middle cerebral artery occlusion in the rat: temporal evolution, regional extent, and comparison with histology. Magn Reson Med 34: 824-834.
15. Jacobs MA, Windham JP, Soltanian-Zadeh H, Peck DJ, Knight RA. 1999. Registration and warping of magnetic resonance images to histological sections. Med Phys 26: 1568-1578.
16. Jelkmann W, Hellwig-Burgel T. 2001. Biology of erythropoietin. Adv Exp Med Biol 502: 169-187.
17. Kraemer M, Schormann T, Hagemann G, Qi B, Witte OW, Seitz RJ. 2004. Delayed shrinkage of the brain after ischemic stroke: preliminary observations with voxel-guided morphometry. J Neuroimag 14: 265-272.
18. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. 1994. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25: 1794-8179.
19. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M. 2004. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242.
20. Li L, Jiang Q, Zhang L, Ding G, Zhang ZG, Li Q, Ewing JR, Lu M, Panda S, Ledbetter KA, Whitton PA, Chopp M. 2007.Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Brain Res 1132: 185-192.
21. Li L, Jiang Q, Ding G, Zhang L, Zhang ZG, Li Q, Panda S, Kapke A, Lu M, Ewing JR, Chopp M. 2009. MRI identification of white matter reorganization enhanced by erythropoietin treatment in a rat model of focal ischemia. Stroke 40: 936-941.
22. Morgenstern LB, Staub L, Chan W, Wein TH, Bartholomew LK, King M, Felberg RA, Burgin WS, Groff J, Hickenbottom SL, Saldin K, Demchuk AM, Kalra A, Dhingra A, Grotta JC. 2002. Improving delivery of acute stroke therapy: the TLL Temple Foundation Stroke Project. Stroke 33: 160-166.
23. Ohab JJ, Fleming S, Blesch A, Carmichael ST. 2006. A neurovascular niche for neurogenesis after stroke. J Neurosci 26: 13007-13016.
24. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. 2003. Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 3: 9-20.
25. Parent JM, Silverstein FS. 2007. Replacing neocortical neurons after stroke. Ann Neurol 61: 185-186.
26. Parent JM, Vexler ZS, Gong C, Derugin N, Ferriero DM. 2002. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol 52: 802-813.
27. Peck DJ, Spickler EM, Knight RA, Hearshen DO, Windham JP. 1992. Analysis of the evolution of focal cerebral ischemia in the rat using the eigenimage filter. Magn Reson Med 26: 259-273.
28. Plane JM, Whitney JT, Schallert T, Parent JM. 2008. Retinoic acid and environmental enrichment alter subventricular zone and striatal neurogenesis after stroke. Exp Neurol 214: 125-134.
29. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C. 1999. Cell type specific up-regulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 58: 654-666.
30. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL. 1996. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88: 1576-1582.
31. Sirén AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P. 2001. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98: 4044-4049.
32. Sirén AL, Radyushkin K, Boretius S, Kaemmer D, Riechers CC, Natt O, Sargin D, Watanabe T, Sperling S, Michaelis T, Price J, Meyer B, Frahm J, Ehrenreich H. 2006. Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain 129: 480-489.
33. Taguchi A, Wen Z, Myojin K, Yoshihara T, Nakagomi T, Nakayama D, Tanaka H, Soma T, Stern DM, Naritomi H, Matsuyama T. 2007. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model. Eur J Neurosci 26: 126-133.
34. Teng H, Zhang ZG, Wang L, Zhang RL, Zhang L, Morris D, Gregg SR, Wu Z, Jiang A, Lu M, Zlokovic BV, Chopp M. 2008. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab 28: 764-771.
35. van Gelderen P, de Vleeschouwer MHM, DesPres D, Pekar J, van Zijl PCM, Moonen CTW. 1994. Water diffusion and acute stroke. Magn Reson Med 31: 154-163.
36. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P. 2003. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198: 971-975.
37. Viviani B, Rossi AD, Chow SC, Nicotera P. 1995. Organotin compounds induce calcium overload and apoptosis in PC12 cells. Neurotoxicology 16: 19-25.
38. Wagner KU, Claudio E, Rucker EB III, Riedlinger G, Broussard C, Schwartzberg PL, Siebenlist U, Hennighausen L. 2000. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development 127: 4949-4958.
39. Wakefield AJ, More LJ, Difford J, McLaughlin JE. 1994. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 47: 129-133.
40. Walters RJL, Fox NC, Schott JM, Crum WR, Stevens JM, Rossor MN, Thomas DJ. 2003. Transient ischaemic attacks are associated with increased rates of global cerebral atrophy. J Neurol Neurosurg Psychiatry 74: 213-216.
41. Wang L, Zhang ZG, Wang Y, Zhang RL, Chopp M. 2004. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35: 1732-1737.
42. Wang Y, Zhang ZG, Rhodes K, Renzi M, Zhang RL, Kapke A, Lu M, Pool C, Heavner G, Chopp M. 2007. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol 151: 1377-1384.
43. Wei L, Han BH, Li Y, Keogh CL, Holtzman DM, Yu SP. 2006. Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 317: 109-116.
44. Williams DS, Detre JA, Leigh JS, Koretsky AP. 1992. Magnetic resonance imaging of perfusion using spin inversion of artery water. Proc Natl Acad Sci U S A 89: 212-216.
45. Yu SW, Friedman B, Cheng Q, Lyden PD. 2007. Stroke-evoked angiogenesis results in a transient population of microvessels. J Cereb Blood Flow Metab 27: 755-763.
46. Zhang RL, Chopp M, Zhang ZG, Jiang Q, Ewing JR. 1997. A rat model of focal embolic cerebral ischemia. Brain Res 766: 83-92.
47. Zhang RL, Zhang ZG, Zhang L, Chopp M. 2001. Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience 105: 33-41.
48. Zhang RL, Zhang Z, Wang L, Wang Y, Gousev A, Zhang L, Ho KL, Morshead C, Chopp M. 2004. Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. J Cereb Blood Flow Metab 24: 441-448.
49. Zhang RL, Zhang ZG, Chopp M. 2005. Neurogenesis in the adult ischemic brain: generation, migration, survival, and restorative therapy. Neuroscientist 11: 408-416.
50. Zhang ZG, Chopp M. 2009. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8: 491-500.
51. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. 2000. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106: 829-838.